TrialJournal of the American Academy of Dermatology2017

Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial.

William N William et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.